OTCMKTS:LNDZF Evome Medical Technologies (LNDZF) Stock Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free LNDZF Stock Alerts $0.21 0.00 (0.00%) (As of 04/30/2024 ET) Add Compare Share Share Today's Range$0.21▼$0.2150-Day Range$0.13▼$0.2152-Week Range$0.02▼$0.32VolumeN/AAverage Volume7,738 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Evome Medical Technologies alerts: Email Address Ad Porter & CompanyTrump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. About Evome Medical Technologies Stock (OTCMKTS:LNDZF)Evome Medical Technologies Inc., through its subsidiaries, engages in the development, production, and sale of medical devices and products in the United States. The company's medical devices are used for pain management and physical therapy treatments, including cold/hot therapy products, neuromuscular electrical stimulation devices, transcutaneous electrical nerve stimulation devices, and ultrasound treatment devices. It also offers wearable technology and products that are used to enhance physical stability. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. Evome Medical Technologies Inc. is headquartered in Shirley, New York.Read More LNDZF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LNDZF Stock News HeadlinesApril 12, 2024 | finance.yahoo.comEvome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is CancelledApril 2, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - EVMTMay 1, 2024 | Porter & Company (Ad)Trump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. April 2, 2024 | finance.yahoo.comEvome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition DebtApril 1, 2024 | globenewswire.comEvome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023February 27, 2024 | globenewswire.comEvome Medical Engages ICP Securities Inc. for Automated Market Making ServicesFebruary 15, 2024 | finance.yahoo.comEvome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as ChairmanFebruary 15, 2024 | globenewswire.comEvome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as ChairmanMay 1, 2024 | Porter & Company (Ad)Trump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. February 8, 2024 | finance.yahoo.comEvome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024January 31, 2024 | finance.yahoo.comEvome Medical Technologies Reduces Acquisition Debt, Bolsters Management Team to Support SpaceTeck Knee™ and Reactive Step Trainer 2024 Product Roll-OutJanuary 18, 2024 | finance.yahoo.comSalona Global Finalizes Name Change to Evome Medical Technologies to Reflect Turn Around and New Innovation Focus; Restructures Board of DirectorsJanuary 11, 2024 | finance.yahoo.comSalona Global Announces Exclusive Partnership with Recently Launched U.S. Military Veteran (VA) Focused Distribution CompanyDecember 18, 2023 | finance.yahoo.comSalona Global Announces the Debut of the Biodex Reactive Step Trainer, a Revolutionary Balance Training System to Reduce Falls; Commences AI Enabled Software ComponentDecember 7, 2023 | msn.comScottish medical device consortium wins £3.35m to pursue sustainable techNovember 17, 2023 | msn.comSalona Global announces launch of new device for knee treatmentNovember 16, 2023 | finance.yahoo.comSalona Global Announces the Debut of the Biodex SpaceTek Knee™, a Revolutionary Portable Isokinetic Knee Dynamometer Medical Device Developed in NASA CollaborationNovember 15, 2023 | finance.yahoo.comSalona Global Completes Turn Around Plan with Profitable Third Quarter, Posting Record Results with 18.5% Quarterly Organic Revenue Growth and 29% Quarterly Gross Profit Growth; Generates $749,425 in Adjusted EBITDA for the QuarterNovember 14, 2023 | finance.yahoo.comSalona Global Showcases Biodex Products at Medica Trade Fair in Düsseldorf, Germany; Expanding Access to International MarketsOctober 28, 2023 | msn.comMedAlliance revolutionising Healthcare through innovation with a global leader CordisOctober 25, 2023 | finance.yahoo.comSalona Global Announces Large International Order from Polish Distributor Expected to be Delivered in the Current Quarter; Increases Year-over-Year Revenues 157% For the Polish MarketOctober 23, 2023 | businesswire.comGlobal $2.19 Bn Wearable Heart Monitoring Devices Markets, 2017-2022, 2022-2027F, 2032F: Diagnostic And Monitoring Devices, Therapeutic Devices, Electric Pulse, Optical ...October 19, 2023 | finance.yahoo.comSalona Global Announces Plans to Change Name to Evome Medical Technologies Inc.; Confirms Positive Adjusted EBITDA and Net Profit for Q3 2023; Appoints New CFOSeptember 18, 2023 | finance.yahoo.comSalona Global Announces Expansion of Bank LineAugust 29, 2023 | benzinga.comMedical Device Contract Manufacturing Market Envisioned at $118.9 Billion by 2027August 17, 2023 | benzinga.comGlobal $30+ Bn Medical Digital Imaging System Markets to 2030: Expanding Role in Preventive Healthcare Drives Market GrowthAugust 15, 2023 | msn.comSalona Global Medical Device GAAP EPS of -$0.02, revenue of $16.6MSee More Headlines Receive LNDZF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evome Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/01/2024Next Earnings (Estimated)5/14/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:LNDZF CUSIPN/A CIK1617765 Webwww.inspirafin.ca Phone(800) 760-6826FaxN/AEmployees144Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesJeffrey ChuExecutive OfficerMr. Michael Seckler (Age 50)CEO & Executive Director Ms. Cherine Pottinger-Harris (Age 43)Principal Accounting Officer & Interim Chief Financial Officer Mr. Joseph G. Martinez Esq. (Age 66)Senior VP of Legal & Compliance, General Counsel and Secretary Mr. Jethro Rothe-KushelVice President of Capital Markets & Financial CommunicationsKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors LNDZF Stock Analysis - Frequently Asked Questions How have LNDZF shares performed in 2024? Evome Medical Technologies' stock was trading at $0.1516 at the start of the year. Since then, LNDZF stock has increased by 38.5% and is now trading at $0.21. View the best growth stocks for 2024 here. When is Evome Medical Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our LNDZF earnings forecast. How do I buy shares of Evome Medical Technologies? Shares of LNDZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LNDZF) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTrackerNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingForget Nvidia. This is the future of AIPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evome Medical Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
